Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Medicure Inc (MCUJF)

Medicure Inc (MCUJF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Medicure Inc 2 - 1250 Waverley Street Winnipeg A2 R3T 6C6 CAN

www.medicure.com P: 204-487-7412

Description:

Medicure Inc is a cardiovascular drug discovery and development company focused on developing effective therapeutics for unmet needs in the field of cardiovascular medicine. In addition to MC-4232, they are also conducting Phase II clinical trials with MC-1, which is focused on the prevention and treatment of ischemia, ischemic reperfusion injury, and stroke.

Key Statistics

Overview:

Market Capitalization, $K 7,723
Enterprise Value, $K 3,003
Shares Outstanding, K 10,436
Annual Sales, $ 16,070 K
Annual Net Income, $ -680 K
Last Quarter Sales, $ 3,730 K
Last Quarter Net Income, $ -1,150 K
EBIT, $ -630 K
EBITDA, $ 980 K
60-Month Beta 0.92
% of Insider Shareholders 12.90%
% of Institutional Shareholders 0.00%
Float, K 9,090
% Float 87.10%
Short Volume Ratio 0.07

Growth:

1-Year Return -23.01%
3-Year Return 12.12%
5-Year Return -86.01%
5-Year Revenue Growth -28.45%
5-Year Earnings Growth -138.89%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.10 on 04/08/24
Latest Earnings Date 05/24/24
Earnings Per Share ttm -0.06
EPS Growth vs. Prev Qtr -1,100.00%
EPS Growth vs. Prev Year -433.33%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 11/06/12

MCUJF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -4.29%
Return-on-Assets % -3.14%
Profit Margin % -4.23%
Debt/Equity 0.00
Price/Sales 0.48
Price/Cash Flow 8.35
Price/Book 0.52
Book Value/Share 1.41
Interest Coverage -14.20
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar